Cost utility of drugs for multiple sclerosis. Analysis goes too far.
Ellis
S J
SJ
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D015276:Health Care Rationing; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D019057:Quality-Adjusted Life Years
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a